- Home
- ESPR vs NL Comparison
ESPR vs NL Comparison
Compare ESPR & NL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- NL
- Stock Information
- Founded
- ESPR 2008
- NL 1891
- Country
- ESPR United States
- NL United States
- Employees
- ESPR N/A
- NL N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- NL Major Chemicals
- Sector
- ESPR Health Care
- NL Industrials
- Exchange
- ESPR Nasdaq
- NL Nasdaq
- Market Cap
- ESPR 410.2M
- NL 389.8M
- IPO Year
- ESPR 2013
- NL N/A
- Fundamental
- Price
- ESPR $1.89
- NL $7.26
- Analyst Decision
- ESPR Buy
- NL Sell
- Analyst Count
- ESPR 6
- NL 1
- Target Price
- ESPR $7.25
- NL $6.00
- AVG Volume (30 Days)
- ESPR 5.1M
- NL 32.6K
- Earning Date
- ESPR 02-25-2025
- NL 03-05-2025
- Dividend Yield
- ESPR N/A
- NL 4.50%
- EPS Growth
- ESPR N/A
- NL N/A
- EPS
- ESPR N/A
- NL 1.19
- Revenue
- ESPR $295,451,000.00
- NL $150,690,000.00
- Revenue This Year
- ESPR $186.04
- NL $2.18
- Revenue Next Year
- ESPR $11.25
- NL $2.50
- P/E Ratio
- ESPR N/A
- NL $6.05
- Revenue Growth
- ESPR 187.12
- NL N/A
- 52 Week Low
- ESPR $1.58
- NL $5.00
- 52 Week High
- ESPR $3.94
- NL $9.42
- Technical
- Relative Strength Index (RSI)
- ESPR 39.38
- NL 37.40
- Support Level
- ESPR $1.71
- NL $6.86
- Resistance Level
- ESPR $2.26
- NL $8.34
- Average True Range (ATR)
- ESPR 0.14
- NL 0.36
- MACD
- ESPR -0.01
- NL -0.09
- Stochastic Oscillator
- ESPR 33.33
- NL 9.38
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About NL NL Industries Inc.
NL Industries Inc operates in the component products industry through its majority-owned subsidiary, CompX International Inc. It manufactures engineered components that are sold to a range of industries, including recreational transportation, postal, office and institutional furniture, cabinetry, tool storage, healthcare, gas stations and vending equipment. CompX has three production facilities in the United States, through which it produces a precision ball bearing slide, security products, and ergonomic computer support systems. The company derives majority of its revenue from Europe.